A detailed history of Vontobel Holding Ltd. transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 24,000 shares of RPTX stock, worth $68,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,000
Previous 20,000 20.0%
Holding current value
$68,160
Previous $66,000 24.24%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$2.75 - $3.99 $11,000 - $15,960
4,000 Added 20.0%
24,000 $82,000
Q2 2024

Aug 13, 2024

BUY
$3.02 - $4.7 $15,100 - $23,500
5,000 Added 33.33%
20,000 $66,000
Q4 2023

Jan 29, 2024

BUY
$3.22 - $11.79 $48,300 - $176,850
15,000 New
15,000 $109,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $119M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.